Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- Acronyms RE-Kinect
- Sponsors Neurocrine Biosciences
- 07 Nov 2017 According to a Neurocrine Biosciences media release, data will be presented at the 2017 Neuroscience Education Institute Congress.
- 19 Sep 2017 New trial record
- 15 Sep 2017 According to a Neurocrine Biosciences media release, data will be presented at the 2017 Annual Psych Congress annual meeting.